MCL1 and non-small cell lung carcinoma: The response to ABT-263 is closed to the expression of Mcl-1 protein in small cell lung cancer (SCLC) cells.82 However, low expression of Mcl-1 in NSCLC cells could not imply that ABT-263 is of therapeutic significance.